Crossmark

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older

Crossref DOI link: https://doi.org/10.1038/s41409-022-01833-0

Published Online: 2022-10-04

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Backhaus, Donata

Brauer, Dominic

Pointner, Rosmarie

Bischof, Lara

Vucinic, Vladan https://orcid.org/0000-0002-8398-285X
Franke, Georg-Nikolaus https://orcid.org/0000-0001-8239-002X
Niederwieser, Dietger https://orcid.org/0000-0002-4737-1103
Platzbecker, Uwe

Jentzsch, Madlen https://orcid.org/0000-0002-2270-0804
Schwind, Sebastian https://orcid.org/0000-0002-1315-2332
Funding

Funding for this research was provided by:

Zusammen gegen den Krebs e.V.

University Leipzig

DGIM
License Information

Text and Data Mining valid from 2022-10-04

Version of Record valid from 2022-10-04
More Information

Article History

Received: 12 March 2022

Revised: 6 September 2022

Accepted: 12 September 2022

First Online: 4 October 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below